Market Overview

Global Alpha-1 Antitrypsin Drugs Market 2018-2022| Rising Patient Assistance Programs to Spur Growth| Technavio

Share:

The global Alpha-1 antitrypsin drugs market 2018-2022 is expected to
post a CAGR of close to 11% during the forecast period, according to the
latest market research report by Technavio.

This press release features multimedia. View the full release here:
https://www.businesswire.com/news/home/20180823005355/en/

Technavio has published a new market research report on the global alpha-1 antitrypsin drugs market  ...

Technavio has published a new market research report on the global alpha-1 antitrypsin drugs market from 2018-2022. (Graphic: Business Wire)

A key factor driving the growth of the market is improving the diagnosis
of Alpha-1 antitrypsin deficiency (AATD). Detection is an important step
in treating any disease or deficiency. However, AATD is difficult to
diagnose in most of the cases. As per the Alpha-1 foundation, about 3%
of all the patients detected with COPD may have undetected AATD. To
combat this, in the last few years several awareness programs conducted
around the world to recognize and differentiate AATD from other diseases.

This market research report on the global
Alpha-1 antitrypsin drugs market 2018-2022
also provides an
analysis of the most important trends expected to impact the market
outlook during the forecast period. Technavio classifies an emerging
trend as a major factor that has the potential to significantly impact
the market and contribute to its growth or decline.

This report is available at a USD 1,000 discount for a limited time
only:
View
market snapshot before purchasing

In this report, Technavio highlights the rising patient assistance
programs as one of the key emerging trends in the global Alpha-1
antitrypsin drugs market:

Global Alpha-1 antitrypsin drugs market: Rising
patient assistance programs

Patient assistance programs are sponsored by drug companies, doctors,
patient, and civic groups. The program helps uninsured patients from
low-income groups to get free or brand-name medications at low prices.

"Several vendors run programs to assist patients with AATD treatment.
Alpha-1 foundation Oxygen Travel Fund is one such program that provides
oxygen and equipment for individuals who lack the financial resources to
visit their physicians, hospitals, and Alpha-1 educational events,"
says
a senior analyst at Technavio for research on cardiovascular and
metabolic disorders.

Global Alpha-1 antitrypsin drugs market:
Segmentation analysis

This market research report segments the global Alpha-1 antitrypsin
drugs market by route of administration (parenteral and inhalation) and
geographical regions (APAC, EMEA, and the Americas).

The Americas led the market in 2017 with a market share of more than
66%, followed by APAC and EMEA respectively. Among the regions, EMEA is
expected to witness maximum incremental growth during the forecast
period.

Looking for more information on this market? Request
a free sample report

Technavio's sample reports are free of charge and contain multiple
sections of the report such as the market size and forecast, drivers,
challenges, trends, and more.

Some of the key topics covered in the report include:

Market Landscape

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

Market Sizing

  • Market definition
  • Market size and forecast

Five Forces Analysis

Market Segmentation

Geographical Segmentation

  • Regional comparison
  • Key leading countries

Market Drivers

Market Challenges

Market Trends

Vendor Landscape

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Competitive scenario

About Technavio

Technavio
is a leading global technology research and advisory company. Their
research and analysis focuses on emerging market trends and provides
actionable insights to help businesses identify market opportunities and
develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio's report library consists
of more than 10,000 reports and counting, covering 800 technologies,
spanning across 50 countries. Their client base consists of enterprises
of all sizes, including more than 100 Fortune 500 companies. This
growing client base relies on Technavio's comprehensive coverage,
extensive research, and actionable market insights to identify
opportunities in existing and potential markets and assess their
competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team
at media@technavio.com.

View Comments and Join the Discussion!